on Facebook
on Twitter
on YouTube
Document Information
Military Use of Drugs Not Yet Approved by the FDA for CW/BW Defense
Lessons from the Gulf War
The confrontation that began when Iraq invaded Kuwait in August 1990 brought with it the threat that chemical and biological weapons might be used against the more than half a million military personnel the United States deployed to the region. To protect these troops from such threats, the Department of Defense wished to use drugs and vaccines that, not having been tested for use in these specific situations, were considered “investigational” by the federal Food and Drug Administration. This report examines the history of the Interim Rule, adopted in December 21, 1990, that authorized the Commissioner of Food and Drugs to waive informed consent for the use of investigational drugs and vaccines for certain military uses; how this authority was used for pyridostigmine bromide and botulinum toxoid during the Gulf War; and the subsequent controversy surrounding the rule, its application, and its implications. The report then analyzes the issues the Interim Rule raised when investigational drugs are used for such purposes and makes recommendations for dealing with similar situations in the future.
See Also:
Support RAND Research — Buy This Product!
Paperback Cover Price: $20.00
Discounted Web Price: $18.00
Pages: 122
ISBN/EAN: 0-8330-2683-6
Contents
Preface HTML
Figure and Tables HTML
Summary HTML
Acknowledgments HTML
Glossary HTML
Chapter One:
Introduction HTML
Chapter Two:
The History of the Interim Rule HTML
Chapter Three:
What Uses of Drugs Are Investigational? HTML
Chapter Four:
The Interim Rule and Its Alternatives HTML
Chapter Five:
Broader Issues HTML
Chapter Six:
Conclusions and Recommendations HTML
Chapter Seven:
Postscript HTML
References HTML
This research was sponsored by RAND's National Security Research Division and RAND Health.
The monograph/report was a product of the RAND Corporation from 1993 to 2003. RAND monograph/reports presented major research findings that addressed the challenges facing the public and private sectors. They included executive summaries, technical documentation, and synthesis pieces.
The RAND Corporation is a nonprofit research organization providing objective analysis and effective solutions that address the challenges facing the public and private sectors around the world. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.
* RAND research is conducted across divisions, centers, and projects; these organizational components are represented in the "Related RAND Divisions" section above.
Top
RAND® is a registered trademark. Copyright © 1994-2009 RAND Corporation. Last Modified: December 07, 2007 